Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives

被引:54
作者
Archer, David F. [1 ]
机构
[1] Eastern Virginia Med Sch, Clin Res Ctr, Contracept Res & Dev Program, Norfolk, VA 23507 USA
关键词
oral contraceptives; continuous use; menstrual cycle symptoms; pill-free period;
D O I
10.1016/j.contraception.2006.06.003
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
As many as 80% of reproductive-aged women experience physical changes associated with menstruation, and 20% to 40% experience menstrual-cycle-related symptoms. Decades of research in women with menstrual disorders, such as dysmenorrhea and menorrhagia, have shown that continuous use of oral contraceptives (OCs), without the hormone-free interval, is a safe and effective method to relieve these symptoms and ultimately induce amenorrhea in many women. If given the opportunity, a majority of women would opt for extended-cycle or continuous regimens, and numerous clinical trials have shown that continuous OC regimens induce amenorrhea in 80% to 100% of women by 10 to 12 months of use. For women who do not wish to become pregnant, a continuous OC regimen should be an available option. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 82 条
  • [1] American College of Obstetricians and Gynecologists, 2000, ACOG PRACT B, V15, P1, DOI DOI 10.1016/S0029-7844(99)00580-3
  • [2] AN EPIDEMIOLOGIC-STUDY OF YOUNG-WOMEN WITH DYSMENORRHEA
    ANDERSCH, B
    MILSOM, I
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 144 (06) : 655 - 660
  • [3] Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen
    Anderson, FD
    Hait, H
    Hsiu, J
    Thompson-Graves, AL
    Wilborn, WH
    Willlams, RF
    [J]. CONTRACEPTION, 2005, 71 (01) : 55 - 59
  • [4] A multicenter, randomized study of an extended cycle oral contraceptive
    Anderson, FD
    Hait, H
    [J]. CONTRACEPTION, 2003, 68 (02) : 89 - 96
  • [5] [Anonymous], EPILESPY OTHER CHRON
  • [6] Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms
    Apter, D
    Borsos, A
    Baumgärtner, W
    Melis, GB
    Vexiau-Robert, D
    Colligs-Hakert, A
    Palmer, M
    Kelly, S
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2003, 8 (01) : 37 - 51
  • [7] Menstrual bleeding patterns in pre- and perimenopausal women: a population-based prospective diary study
    Astrup, K
    Olivarius, ND
    Moller, S
    Gottschau, A
    Karlslund, W
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2004, 83 (02) : 197 - 202
  • [8] The Coraliance study: non-compliant behavior. Results after a 6-month follow-up of patients on oral contraceptives
    Aubeny, E
    Buhler, M
    Colau, JC
    Vicaut, E
    Zadikian, M
    Childs, M
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2004, 9 (04) : 267 - 277
  • [9] Endometrial development in association with ovarian follicular waves during the menstrual cycle
    Baerwald, AR
    Pierson, RA
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2004, 24 (04) : 453 - 460
  • [10] Baird DT, 2001, HUM REPROD, V16, P1527